Sign inJoin waitlistJoin the waitlist

Sherif Farag

Physician in Hematology and Oncology · Community Health Network, Inc.

Credentials: · · · ·

History

Community Health Network, Inc.
Present

Roswell Park Comprehensive Cancer Center
1993–1997
Internal Medicine
University at Buffalo School of Medicine
1994–1997
University of Melbourne
1994–1995
St. Vincent's Hospital
1991–1994
University of Melbourne
1990–1993
The Royal Melbourne Hospital
1986–1990
University of Melbourne
1987–1990
University of Melbourne
1981–1986
University of MelbourneInternship
1984–1985

Research

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
Blood · 2002 · First of 5 authors · Corresponding · 381 citations
Human natural killer cell development and biology
Review · Blood Reviews · 2006 · First of 2 authors · Corresponding · 367 citations
CERAPP: Collaborative Estrogen Receptor Activity Prediction Project
Environmental Health Perspectives · 2016 · 267 citations

Rafat Abonour
12 papers
Jennifer Schwartz
11 papers
MC
Michael Caligiuri
11 papers
TL
Thomas Lin
11 papers
Michael Robertson
10 papers
Daniel Weisdorf
9 papers
Edward Copelan
8 papers
Guido Marcucci
8 papers
JB
John Byrd
8 papers
SP
Sam Penza
8 papers
Belinda Copelan
7 papers
Craig Hofmeister
7 papers

Grants

Inhibition of PGE2 for Mobilization of Autologous Peripheral Blood Stem Cells
National Cancer Institute · R01
Contact PI · $1.6M · Indiana University Indianapolis
2014–2020
Enhancing Engraftment of Cord Blood by CD26 Inhibition
National Heart, Lung, and Blood Institute · R01
PI · $3.6M · Indiana University Indianapolis
2012–2018
Multiple Kinase Target Inhibition with EMND-2076 in Multiple Myeloma
National Cancer Institute · R21
Contact PI · $629.5K · Indiana University Indianapolis
2010–2013
DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*
National Cancer Institute · P01
Project lead · $1.5M · Ohio State University
2005–2011

Clinical trials

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Principal investigator · Completed · Phase 2
Sherif S. Farag
2016–2019
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Principal investigator · Completed · Phase 2
Sherif S. Farag
2014–2019
Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant
Principal investigator · Completed · Phase 2
Sherif S. Farag
2012–2017
Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
Principal investigator · Terminated · Phase 1, Phase 2
Sherif S. Farag
2011–2017